[1] KOBAYASHI J. Search for new bioactive marine natural products and application to drug development[J]. Chem Pharm Bull (Tokyo),2016, 64(8):1079-1083.
[2] MOLINSKI TF, DALISAY DS, LIEVENS SL, et al. Drug development from marine natural products[J]. Nat Rev Drug Discov,2009, 8(1):69-85.
[3] LI J, GU BB, SUN F, et al. Sesquiterpene quinones/hydroquinones from the Marine Sponge Spongia pertusa Esper[J],J Nat Prod,2017, 80(5):1436-1445.
[4] KONG D, AOKI S, SOWA Y, et al. Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces G1 arrest or apoptosis in different leukemia cells[J]. Mar Drugs, 2008, 6(3):480-488.
[5] AOKI S, KONG D, MATSUI K, et al. Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells[J]. Anticancer Drugs,2004, 15(4):363-369.
[6] AOKI S, KONG D, MATSUI K, et al. Sesquiterpene aminoquinones, from a marine sponge, induce erythroid differentiation in human chronic myelogenous leukemia, K562 cells[J]. Chem Pharm Bull (Tokyo),2004, 52(8):935-937.
[7] KONG D, YAMORI T, KOBAYASHI M, et al. Antiproliferative and antiangiogenic activities of smenospongine, a marine sponge sesquiterpene aminoquinone[J]. Mar Drugs,2011, 9(2):154-161.
[8] SMITH RA, COKKINIDES V, BROOKS D, et al. Cancer screening in the United States, 2010:a review of current American Cancer Society guidelines and issues in cancer screening[J]. CA Cancer J Clin,2010, 60(2):99-119.
[9] QUEIROZ EA, PUUKILA S, EICHLER R, et al. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells[J]. PLoS ONE,2014, 9(5):e98207.
[10] KONDRACKI ML, GUYOT M. Smenospongine:a cytotoxic and antimicrobial aminoquinone isolated from ja:math sp[J]. Tetrahedron Letters,1987, 28(47):5815-5818.
[11] LOPEZ J, TAIT SW. Mitochondrial apoptosis:killing cancer using the enemy within[J]. Br J Cancer,2015, 112(6):957-962.
[12] HUANG HL, CHAO MW, LI YC, et al. MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis, and potentiates antineoplastic effect of cisplatin in ovarian cancer[J]. Sci Rep,2016, 6:31664.
[13] ROOVERS K, ASSOIAN RK. Integrating the MAP kinase signal into the G1 phase cell cycle machinery[J]. Bioessays,2000, 22(9):818-826.
[14] ZHANG X, WANG X, WU T, et al. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation[J]. Sci Rep,2015, 5:12579.
[15] JUNTTILA MR, LI SP, WESTERMARCK J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival[J]. FASEB J,2008, 22(4):954-965.
[16] SCHROETER H, BOYD CS, AHMED R, et al. c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function:new target proteins for JNK signalling in mitochondrion-dependent apoptosis[J]. Biochem J,2003, 372(Pt 2):359-369.